International cooperation in the expansion of a newborn screening programme in Lebanon: a possible model for other programmes
- 21 November 2008
- journal article
- Published by Wiley in Journal of Inherited Metabolic Disease
- Vol. 31 (S2), 441-446
- https://doi.org/10.1007/s10545-008-1008-5
Abstract
Tandem mass spectrometry (MS/MS) is rapidly gaining support, even in less-developed nations, as the method of choice for the newborn screening of metabolic disorders, although difficulties in acquiring this technology may at times be major obstacles in several Middle East and North Africa (MENA) countries. In Lebanon, international cooperation allowed this acquisition at the Newborn Screening Laboratory (NSL) of the Saint Joseph University (USJ) in the capital city of Beirut. NSL is currently screening up to 20% of all newborns in Lebanon. The expansion was made possible through initial collaboration with the Metabolic Laboratory at the Hamburg University Medical Center (HUMC) and subsequently with other centres. During phase I of the expansion (2006–2007), blood spots were shipped to HUMC with rapid couriers twice a week and electronic reports were sent back generally within 4 days after shipment. Positive cases were recalled to NSL and new specimens were sent back for confirmation at HUMC. During that first phase, the Beirut staff received training at the HUMC and in other centres. Phase II was a transitory period of 4 months during which machines were installed in Beirut and working procedures were adopted and documented. The activity has now entered a consolidation phase (Phase III) in which all measurements are exclusively performed in Beirut while HUMC acts as a backup centre. International cooperation remains crucial for periodic quality assurance procedures, and for supporting the transformation of the USJ-NSL into a training centre able to transfer MS/MS technology to the MENA region.Keywords
Funding Information
- Saint Joseph University
- College of Natural Resources and Sciences, Humboldt State University
This publication has 16 references indexed in Scilit:
- Second-Tier Test for Quantification of Alloisoleucine and Branched-Chain Amino Acids in Dried Blood Spots to Improve Newborn Screening for Maple Syrup Urine Disease (MSUD)Clinical Chemistry, 2008
- Newborn screening: Experiences in the Middle East and North AfricaJournal of Inherited Metabolic Disease, 2007
- Newborn screening in Latin America at the beginning of the 21st centuryJournal of Inherited Metabolic Disease, 2007
- Reduction of the false‐positive rate in newborn screening by implementation of MS/MS‐based second‐tier tests: The Mayo Clinic experience (2004–2007)Journal of Inherited Metabolic Disease, 2007
- Newborn screening in the Asia Pacific regionJournal of Inherited Metabolic Disease, 2007
- Expanded newborn screening in Europe 2007Journal of Inherited Metabolic Disease, 2007
- Implementation of extended neonatal screening and a metabolic unit in the State of Qatar: Developing and optimizing strategies in cooperation with the Neonatal Screening Center in HeidelbergJournal of Inherited Metabolic Disease, 2007
- Prevalence of G6PD deficiency and knowledge of diagnosis in a sample of previously unscreened Lebanese males: clinical implicationsJournal of Medical Screening, 2006
- Screening Newborns for Inborn Errors of Metabolism by Tandem Mass SpectrometryNew England Journal of Medicine, 2003
- Diagnosis of isovaleric acidaemia by tandem mass spectrometry: False positive result due to pivaloylcarnitine in a newborn screening programmeJournal of Inherited Metabolic Disease, 1998